Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

23

Number of overlapping holdings

82.1%

% of PBE's 28 holdings also in XBI

17.3%

% of XBI's 134 holdings also in PBE

Overlap by Weight
Sector Drift (PBE minus XBI)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PBE
Weight
in XBI
Overlap
NEUROCRINE BIOSCIENCES INC 3.2% 2.8% 2.8%
NATERA INC 5.3% 2.5% 2.5%
GILEAD SCIENCES INC 5.3% 2.5% 2.5%
AMGEN INC 4.8% 2.4% 2.4%
INCYTE CORP 5.0% 2.4% 2.4%

Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to XBI
ILLUMINA INC 4.6%
ROYALTY PHARMA PLC CLASS A 3.2%
AXSOME THERAPEUTICS, INC. 3.0%
GILEAD SCIENCES INC 2.9%
NATERA INC 2.9%
COLLEGIUM PHARMACEUTICAL, INC. 2.8%
BIO-TECHNE CORPORATION 2.7%
INCYTE CORP 2.6%
BIOCRYST PHARMACEUTICALS INC 2.6%
ACADIA PHARMACEUTICALS INC 2.6%
PBE Underweight Relative to XBI
ALNYLAM PHARMACEUTICALS INC -2.5%
ABBVIE INC -2.5%
INSMED INC -2.4%
VERTEX PHARMACEUTICALS INC -2.3%
VAXCYTE, INC. -2.3%
MODERNA, INC. -2.1%
MADRIGAL PHARMACEUTICALS, INC. -1.9%
VIKING THERAPEUTICS, INC. -1.5%
BRIDGEBIO PHARMA, INC. -1.5%
ADMA BIOLOGICS, INC. -1.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY